Samir Gupta
Expertise in
5
conditions

Dr. Samir Gupta

Infectious Disease
Eskenazi Health
720 Eskenazi Ave, 
Indianapolis, IN 
Expertise in
5
conditions
Eskenazi Health
720 Eskenazi Ave, 
Indianapolis, IN 

Overview

Samir Gupta is an Infectious Disease provider practicing medicine in Indianapolis, Indiana.

Dr. Gupta is highly rated in 5 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Colonoscopy, and Endoscopy.

He is actively involved in clinical research, co-authoring 697 peer reviewed articles and participating in 6 clinical trials.

Specialties

Infectious Disease

Licenses

Internal Medicine in IN

Hospital Affiliations

Indiana University Health

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Eskenazi Health
720 Eskenazi Ave, Indianapolis, IN 46202
Other Locations
Indiana University Medical Center
545 Barnhill Dr, Indianapolis, IN 46202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Biological
Study Drug: GSK3810109A
Study Phase: Phase 2
A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1 Infected Adults Who Are Virologically Suppressed and Participated in Study LAI116482
A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1 Infected Adults Who Are Virologically Suppressed and Participated in Study LAI116482
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Long-acting cabotegravir, Long-acting rilpivirine, Rilpivirine, Dolutegravir
Study Phase: Phase 2
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
Personalized Biomedical Risk Assessment for Smoking Cessation in Chronic Obstructive Pulmonary Disease
Personalized Biomedical Risk Assessment for Smoking Cessation in Chronic Obstructive Pulmonary Disease
Enrollment Status: Unknown
Publish Date: February 17, 2023
Intervention Type: Behavioral
Internet-Based Cognitive Behavioral Therapy to Treat Insomnia in HIV: A Pilot Trial
Internet-Based Cognitive Behavioral Therapy to Treat Insomnia in HIV: A Pilot Trial
Enrollment Status: Completed
Publish Date: February 21, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
A Randomized, Controlled Pilot Trial Assessing the Utility of Cognitive Behavioral Therapy to Improve Endothelial Function and Reduce Inflammation in Depressed, Virologically-Suppressed, Antiretroviral-Treated, HIV-infected Adults
A Randomized, Controlled Pilot Trial Assessing the Utility of Cognitive Behavioral Therapy to Improve Endothelial Function and Reduce Inflammation in Depressed, Virologically-Suppressed, Antiretroviral-Treated, HIV-infected Adults
Enrollment Status: Completed
Publish Date: July 14, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
View 5 Less Clinical Trials

695 Total Publications

Bridging the Gap: Examining the Association of Travel Burden With Treatment Administration and Survival in Stage II/III Gastric Cancer.
Bridging the Gap: Examining the Association of Travel Burden With Treatment Administration and Survival in Stage II/III Gastric Cancer.
Journal: JCO oncology practice
Published: June 23, 2026
Similar Doctors
Expertise in
3
conditions
Dr. Chandy John
Infectious Disease
Expertise in
3
conditions
Dr. Chandy John
Infectious Disease
Referral may be required

Riley Hospital For Children At Indiana University Health

705 Riley Hospital Dr, 
Indianapolis, IN 
 (1.2 miles away)
317-944-5000
Languages Spoken:
English
See accepted insurances

Chandy John is an Infectious Disease provider practicing medicine in Indianapolis, Indiana. Dr. John is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Malaria, Primary Amebic Meningoencephalitis, Multisystem Inflammatory Syndrome in Children (MIS-C), and Bacterial Meningitis.

Expertise in
4
conditions
Dr. David Aronoff
Infectious Disease
Expertise in
4
conditions
Dr. David Aronoff
Infectious Disease
Referral may be required

Indiana University Health University Hospital

550 University Blvd, 
Indianapolis, IN 
 (1.2 miles away)
317-944-5000
Languages Spoken:
English
See accepted insurances

David Aronoff is an Infectious Disease provider practicing medicine in Indianapolis, Indiana. Dr. Aronoff is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Streptococcal Group B Infection, Strep Throat, Sepsis, and Pneumonia.

Expertise in
3
conditions
Dr. Stanley Spinola
Infectious Disease
Expertise in
3
conditions
Dr. Stanley Spinola
Infectious Disease
Referral may be required

Office

250 N Shadeland Ave, 
Indianapolis, IN 
 (6.3 miles away)
317-944-8660
Languages Spoken:
English
See accepted insurances

Stanley Spinola is an Infectious Disease provider practicing medicine in Indianapolis, Indiana. Dr. Spinola is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Chancroid, Pustules, Yaws, and Streptococcal Group A Infection.

Frequently Asked Questions about Dr. Samir Gupta

How do I make an appointment with Dr. Samir Gupta?

You can book an appointment with Dr. Samir Gupta by calling their office at 317-880-5475. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Samir Gupta a top-rated expert for Colonoscopy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samir Gupta is classified as an Elite expert for Colonoscopy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Samir Gupta specialize in?

While Dr. Samir Gupta is a Infectious Disease, they have specific expertise in Colonoscopy, Endoscopy, and HIV/AIDS. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Samir Gupta participate in research or clinical trials?

Yes. Dr. Samir Gupta has published 695 articles and abstracts on conditions like Colonoscopy. You can view a list of Dr. Samir Gupta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Samir Gupta accept my insurance?

Dr. Samir Gupta accepts most major insurance plans, including CareSource and Humana. We recommend calling the office directly at 317-880-5475 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gupta's expertise for a condition
ConditionClose
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile